Brett P Monia
CIK 1537529 · Chief Executive Officer · last filed 2026-06-26
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$13.15M
Companies
3
Total Filings
131
Lifetime Open-Market Net
-$67.80M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| IONS | Chief Executive Officer | 245,571 | $53.28 | $13.08M | -$62.52M | 75 | 2026-06-26 |
| CGTX | Director | 73,500 | $0.92 | $67.3K | $0 | 6 | 2026-06-22 |
| IONIS PHARMACEUTICALS INC (ISIS) Delisted | SVP, Antisense Drug Discovery | 4,355 | — | — | -$5.28M | 22 | 2015-07-02 |
Recent Filings · Page 12 of 14
131 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2015-06-10 | IONIS PHARMACEUTICALS INC (ISIS) Delisted | Mixed | — | -$425.1K | EDGAR |
| 2015-01-20 | IONIS PHARMACEUTICALS INC (ISIS) Delisted | Mixed | +2,491 | -$104.3K | EDGAR |
| 2015-01-05 | IONIS PHARMACEUTICALS INC (ISIS) Delisted | Mixed | +122 | $1.2K | EDGAR |
| 2014-08-28 | IONIS PHARMACEUTICALS INC (ISIS) Delisted | Mixed | — | -$789.7K | EDGAR |
| 2014-08-01 | IONIS PHARMACEUTICALS INC (ISIS) Delisted | Sell (S) | −79 | -$2.5K | EDGAR |
| 2014-07-01 | IONIS PHARMACEUTICALS INC (ISIS) Delisted | Other (J) | +76 | $2.3K | EDGAR |
| 2014-01-17 | IONIS PHARMACEUTICALS INC (ISIS) Delisted | Mixed | +1,330 | -$38.7K | EDGAR |
| 2014-01-03 | IONIS PHARMACEUTICALS INC (ISIS) Delisted | Mixed | −283 | -$12.3K | EDGAR |
| 2013-09-23 | IONIS PHARMACEUTICALS INC (ISIS) Delisted | Mixed | — | -$1.39M | EDGAR |
| 2013-08-28 | IONIS PHARMACEUTICALS INC (ISIS) Delisted | Sell (S) | −2,909 | -$74.4K | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.